Europe
The firm, which has revealed profits of £990,837, claims it is the disruptive force in the IP-legal industry
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date
Practitioners and law firms should keep their eyes peeled for the shortlists for our annual awards
Despite a broader slowdown in US IP partner hiring in 2025, litigation demand drove aggressive lateral expansion at select firms
Sponsored
Sponsored
-
Sponsored by Patrinos & KilimirisConstantinos Kilimiris of Patrinos & Kilimiris draws on recent case law in noting that an applicant’s timely action fulfils the urgency requirement for the granting of a preliminary injunction -
Sponsored by InspicosWhile concrete definitions are still lacking, Peter Koefoed of Inspicos says patent applicants seeking protection for second medical uses of products could now find it easier to build their case
-
Sponsored by Bird & BirdMatthias Meyer and Daniel Misch of Bird & Bird consider whether a ruling leaves certain companies facing increased exposure to damages through activities that are causally linked to patent infringement acts
-
Sponsored by Patrinos & KilimirisMaria Kilimiris of Patrinos & Kilimiris commends the approach taken by the Administrative Trademarks Commission in assessing the similarity of marks involving figurative elements and words
-
Sponsored by Maiwald Intellectual PropertyEva Ehlich and Anja Fux of Maiwald summarise an EPO board ruling relating to substances and compositions in the context of medical use claims and how it could affect applicants’ portfolio strategies
-
Sponsored by Gün and PartnersBarış Kalaycı and Begüm Soydan Sayılkan of Gün and Partners explain why trademark infringers have flocked to a popular part of the Turkish coast, and suggest what should be done in response
European Jurisdictions